Zhongchao(ZCMD)
Search documents
美股异动丨众巢医学跌27.43%,为跌幅最大的中概股
Ge Long Hui· 2025-10-10 00:24
| 代码 | 名称 | 最新价 | 涨跌幅 ^ | 涨跌额 | 成交额 | | --- | --- | --- | --- | --- | --- | | ZCMD | 众巢医学 | 0.820 | -27.43% | -0.310 | 103.5万 | | LGCL | 周科任 | 0.1160 | -25.11% | -0.0389 | 189.38万 | | UPC | 大自然药业 | 7.220 | -23.68% | -2.240 | 326.25万 | | CLWT | 欧陆科仪 | 1.320 | -12.00% | -0.180 | 2.13万 | | ZYBT | 正业生物 | 2.720 | -11.69% | -0.360 | 97.44万 | 中概股收盘跌幅前五的个股为:众巢医学跌27.43%,罗科仕跌25.11%,大自然药业跌23.68%,欧陆科 仪跌12%,正业生物跌11.69%。(格隆汇) ...
ZCMD, ABCL, VOR, IXHL, OVID, BFRG Rally After Hours On Clinical Momentum And Recent Updates
RTTNews· 2025-10-02 05:09
Core Insights - Several biotech and healthcare stocks experienced significant after-hours gains on October 1, driven by technical momentum and recent clinical updates rather than new disclosures [1] Company Summaries - Zhongchao Inc. (ZCMD) saw a 14.04% increase in after-hours trading, rising to $1.30 from $1.14, despite no new filings or press releases [2] - AbCellera Biologics Inc. (ABCL) rose 11.41% in after-hours trading, closing at $6.64, following an 18.49% gain during the regular session, attributed to recent clinical trial progress [3][4] - Vor Biopharma Inc. (VOR) surged 9.53% in after-hours trading, recovering from a 19.42% drop during the regular session, with no new updates since a recent announcement regarding clinical data presentation [5] - Incannex Healthcare Inc. (IXHL) gained 6.48% in after-hours trading, partially recovering from a 6.94% drop, with the latest update showing positive Phase 2 trial results for PSX-001 [6] - Ovid Therapeutics Inc. (OVID) shares rose 8.03% in after-hours trading, building on a 5.38% gain during the regular session, with recent earnings report indicating a narrower net loss and higher revenue [7] - Bullfrog AI Holdings Inc. (BFRG) advanced 3.44% in after-hours trading, following a 3.57% rise during the regular session, after announcing an expansion of its sales and marketing team [8]
众巢医学上涨21.72%,报1.05美元/股,总市值2651.15万美元
Jin Rong Jie· 2025-08-25 17:00
Core Insights - ZCMD's stock price increased by 21.72% to $1.05 per share, with a total market capitalization of $26.51 million as of August 26 [1] - The company's total revenue for the year ending December 31, 2024, is projected to be $15.86 million, representing an 18.37% year-over-year decline [1] - The net profit attributable to the parent company is expected to be -$0.6432 million, showing a significant improvement of 94.33% year-over-year [1] Company Overview - ZCMD is a Cayman Islands-registered holding company established on April 16, 2019, and operates through its subsidiary, ZCMD Medical Technology (Shanghai) Co., Ltd. [1] - The company focuses on medical education and patient education, offering three main business segments: 1. Medical MOOCs, 2. Sunshine Health Classroom, 3. Patient Assistance Program [1] - The Medical MOOCs platform combines advanced medical education concepts with modern internet technology, providing accessible and continuous learning opportunities for healthcare professionals [1]
众巢医学上涨11.25%,报0.96美元/股,总市值2423.11万美元
Jin Rong Jie· 2025-08-25 14:28
Core Viewpoint - Zhongchao Medical (ZCMD) experienced an 11.25% increase in stock price, reaching $0.96 per share, with a total market capitalization of $24.23 million as of August 25 [1] Financial Performance - For the fiscal year ending December 31, 2024, Zhongchao Medical reported total revenue of $15.86 million, a year-over-year decrease of 18.37% [1] - The company recorded a net profit attributable to shareholders of -$0.6432 million, which represents a significant year-over-year increase of 94.33% [1] Company Overview - Zhongchao Medical was established on April 16, 2019, as an offshore holding company registered in the Cayman Islands, with its operations managed by its domestic subsidiary, Zhongchao Medical Technology (Shanghai) Co., Ltd. [1] - The company operates a digital medical education platform called Medical MOOC, which integrates advanced medical education concepts with modern internet technology, providing accessible and continuous learning opportunities for healthcare professionals [1] - Zhongchao Medical focuses on three main business segments: 1. Medical MOOC, 2. Sunshine Health Classroom, 3. Zhongxun Patient Assistance [1]
众巢医学上涨5.44%,报0.95美元/股,总市值2399.12万美元
Jin Rong Jie· 2025-08-22 13:52
Core Insights - ZCMD's stock opened up by 5.44% on August 22, reaching $0.95 per share with a total market capitalization of $23.99 million [1] - For the fiscal year ending December 31, 2024, ZCMD reported total revenue of $15.86 million, a year-over-year decrease of 18.37%, while the net profit attributable to the parent company was -$0.6432 million, reflecting a year-over-year increase of 94.33% [1] Company Overview - ZCMD is a Cayman Islands-registered holding company established on April 16, 2019, and operates through its subsidiary, ZCMD Medical Technology (Shanghai) Co., Ltd [1] - The company offers a digital medical education platform called Medical MOOC, which integrates advanced medical education concepts with modern internet technology, providing accessible and continuous learning opportunities for healthcare professionals [1] - ZCMD focuses on three main business segments: 1. Medical MOOC, 2. Sunshine Health Classroom, 3. Patient Assistance Program [1]
众巢医学上涨2.44%,报0.91美元/股,总市值2299.11万美元
Jin Rong Jie· 2025-08-21 17:11
Core Viewpoint - Zhongchao Medical (ZCMD) experienced a stock price increase of 2.44% on August 22, reaching $0.91 per share, with a total market capitalization of $22.99 million [1] Financial Performance - As of December 31, 2024, Zhongchao Medical reported total revenue of $15.86 million, a year-over-year decrease of 18.37% [1] - The company recorded a net profit attributable to shareholders of -$0.6432 million, which represents a year-over-year increase of 94.33% [1] Company Overview - Zhongchao Medical was established on April 16, 2019, as an offshore holding company registered in the Cayman Islands, operated by its domestic subsidiary, Zhongchao Medical Technology (Shanghai) Co., Ltd. [1] - The company offers a digital medical education platform called Medical MOOC, which combines advanced medical education concepts with modern internet technology, providing accessible and continuous learning opportunities for healthcare professionals [1] - Zhongchao Medical focuses on three main business segments: 1. Medical MOOC, 2. Sunshine Health Classroom, 3. Zhongxun Patient Assistance [1]
众巢医学上涨6.52%,报0.98美元/股,总市值2474.88万美元
Jin Rong Jie· 2025-08-19 15:45
Core Viewpoint - Zhongchao Medical (ZCMD) experienced a stock price increase of 6.52% on August 19, reaching $0.98 per share, with a total market capitalization of $24.7488 million [1] Financial Performance - As of December 31, 2024, Zhongchao Medical reported total revenue of $15.8648 million, a year-over-year decrease of 18.37% [1] - The company recorded a net profit attributable to shareholders of -$0.6432 million, which represents a year-over-year increase of 94.33% [1] Company Overview - Zhongchao Medical is a foreign holding company registered in the Cayman Islands on April 16, 2019, and operates through its domestic subsidiary, Zhongchao Medical Technology (Shanghai) Co., Ltd. [1] - The subsidiary's platform, Medical MOOC, integrates advanced medical education concepts with modern internet technology, providing accessible and continuous learning opportunities for healthcare professionals [1] - Zhongchao Medical focuses on three main business segments: 1. Medical MOOC, 2. Sunshine Health Classroom, 3. Zhongxun Patient Assistance [1]
众巢医学上涨4.06%,报1.0美元/股,总市值2525.39万美元
Jin Rong Jie· 2025-08-13 19:39
Core Viewpoint - Zhongchao Medical (ZCMD) experienced a 4.06% increase in stock price, reaching $1.00 per share, with a total market capitalization of $25.25 million as of August 14 [1] Financial Performance - For the fiscal year ending December 31, 2024, Zhongchao Medical reported total revenue of $15.86 million, a year-over-year decrease of 18.37% [1] - The company recorded a net profit attributable to shareholders of -$0.6432 million, which represents a significant year-over-year increase of 94.33% [1] Company Overview - Zhongchao Medical was established on April 16, 2019, as an offshore holding company registered in the Cayman Islands, with its operations managed by its domestic subsidiary, Zhongchao Medical Technology (Shanghai) Co., Ltd. [1] - The company operates a digital medical education platform called Medical MOOC, which integrates advanced medical education concepts with modern internet technology, providing accessible and continuous learning opportunities for healthcare professionals [1] - Zhongchao Medical focuses on three main business segments: 1. Medical MOOC, 2. Sunshine Health Classroom, 3. Zhongxun Patient Assistance [1]
众巢医学上涨3.37%,报0.993美元/股,总市值2508.72万美元
Jin Rong Jie· 2025-08-06 19:54
Core Viewpoint - Zhongchao Medical (ZCMD) experienced a 3.37% increase in stock price, reaching $0.993 per share, with a total market capitalization of $25.0872 million as of August 7 [1] Financial Performance - For the fiscal year ending December 31, 2024, Zhongchao Medical reported total revenue of $15.8648 million, a year-on-year decrease of 18.37% [1] - The company recorded a net profit attributable to shareholders of -$0.6432 million, which represents a year-on-year increase of 94.33% [1] Company Overview - Zhongchao Medical was established on April 16, 2019, as an offshore holding company registered in the Cayman Islands, with its operations managed by its domestic subsidiary, Zhongchao Medical Technology (Shanghai) Co., Ltd. [1] - The company operates a digital medical education platform called Medical MOOC, which combines advanced medical education concepts with modern internet technology, providing accessible and continuous learning opportunities for healthcare professionals [1] - Zhongchao Medical focuses on three main business segments: 1. Medical MOOC, 2. Sunshine Health Classroom, 3. Zhongxun Patient Assistance [1]
众巢医学上涨2.91%,报1.06美元/股,总市值2676.91万美元
Jin Rong Jie· 2025-07-29 19:41
Core Viewpoint - Zhongchao Medical (ZCMD) has experienced a stock price increase of 2.91% as of July 30, with a current share price of $1.06 and a total market capitalization of $26.7691 million [1] Financial Performance - For the fiscal year ending December 31, 2024, Zhongchao Medical reported total revenue of $15.8648 million, representing a year-over-year decrease of 18.37% [1] - The company recorded a net profit attributable to the parent company of -$0.6432 million, which is a significant improvement with a year-over-year increase of 94.33% [1] Company Overview - Zhongchao Medical was established on April 16, 2019, as an offshore holding company registered in the Cayman Islands, with its operations managed by its domestic subsidiary, Zhongchao Medical Technology (Shanghai) Co., Ltd. [1] - The company operates a digital medical education platform called Medical MOOC, which integrates advanced medical education concepts with modern internet technology, providing accessible and continuous learning opportunities for healthcare professionals [1] - Zhongchao Medical focuses on three main business segments: 1. Medical MOOC, 2. Sunshine Health Classroom, 3. Zhongxun Patient Assistance [1]